Virtual Reality Brings Live Operations to Many More Medical Students

Operating rooms are designed for maximization of space. That means they are quite small, allowing a minimal number of medical students to view a live surgery, which in turn limits learning opportunities. This setup is inefficient and wasteful, to say the least. But what can be done, given the space restrictions of the average OR?

The answer is virtual reality (VR). At the University of Virginia School of Medicine, students are using a very inexpensive form of VR that allows countless students to view complex operations and invasive procedures as they take place. Using a camera in the OR and an app that creates a dual image, the student’s own smart phone can be used to view the operation.

It’s simple. The app is turned on, and the phone is placed in a cardboard viewer that looks, interestingly, like a View-Master stereoscope toy. In many ways, the same technology is being applied, except of course the images are moving. The student puts the stereoscope up to his or her eyes, and the moving images are rendered into 3-D. It’s almost like they are there.

A combination of the latest smart phone technology with a cardboard stereoscope is bringing more medical students into operating rooms so more students can learn how to do even the rarest procedures. The shortage of space in an OR may not be a critical issue for simple, oft-repeated operations, since a missed opportunity today may be resolved with a new operation of the same kind tomorrow. However, for rare procedures, live viewing access is limited. This simple VR technology makes it possible to keep ORs from being overcrowded while allowing students to optimize their learning.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More